Responses to emerging and re-emerging infectious diseases: One world, One health

por Xu, Jianqing, Xu, Jianguo
Publicado 2018

Innate Immune Response in Respiratory System: A Double-edged Sword Against Virus Infection

por Li, Ang, Xu, Jianqing
Publicado 2021

The Arms Race in the War Between Virus and Host: Implications for Anti-Infection Immunity

por Liu, William J., Xu, Jianqing
Publicado 2022

Multiple Independent Introductions of HIV-1 CRF01_AE Identified in China: What Are the Implications for Prevention?

por Abubakar, Yassir F., Meng, Zhefeng, Zhang, Xiaoyan, Xu, Jianqing
Publicado 2013

Identification of miRNA-mRNA crosstalk in CD4(+) T cells during HIV-1 infection by integrating transcriptome analyses

por Liao, Qibin, Wang, Jin, Pei, Zenglin, Xu, Jianqing, Zhang, Xiaoyan
Publicado 2017

Correction to: Identification of miRNA-mRNA crosstalk in CD4(+) T cells during HIV-1 infection by integrating transcriptome analyses

por Liao, Qibin, Wang, Jin, Pei, Zenglin, Xu, Jianqing, Zhang, Xiaoyan
Publicado 2020

A randomized, double-blind, placebo-controlled phase I trial of inhalation treatment of recombinant TFF2-IFN protein: A multifunctional candidate for the treatment of COVID-19

por Liu, Yan, Zhai, Guanxing, Fu, Weihui, Zhang, Xiaoyan, Xu, Jianqing
Publicado 2022

Escherichia coli adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll-like receptor 4

por Zhang, Wei, Xu, Li, Zhang, Xiaoyan, Xu, Jianqing, Jin, Jun-O
Publicado 2023

OVERCOMING TECHNICAL CHALLENGES OF BISPECIFIC AND MULTI-SPECIFIC ANTIBODIES USING NOVEL TECHNOLOGY PLATFORMS

por Xu, Jianqing, Wang, Shuang, Fan, Xinzhao, Wang, George, Gu, Jijie, Nie, Siwei
Publicado 2023

Efficacy, Stability, and Biosafety of Sifuvirtide Gel as a Microbicide Candidate against HIV-1

por Li, Liangzhu, Ben, Yinyin, Yuan, Songhua, Jiang, Shibo, Xu, Jianqing, Zhang, Xiaoyan
Publicado 2012

Minocycline Down-Regulates Topical Mucosal Inflammation during the Application of Microbicide Candidates

por Li, Liangzhu, Ben, Yinyin, Zhu, Zhaoqin, Li, Weihua, Xu, Jianqing, Zhang, Xiaoyan
Publicado 2012

Development of Skewed Functionality of HIV-1-Specific Cytotoxic CD8(+) T Cells from Primary to Early Chronic Phase of HIV Infection

por Wang, Wanhai, Qiu, Chenli, Qiu, Chao, Wang, Ying, Zhang, Xiaoyan, Xu, Jianqing
Publicado 2012

The Average IFN-γ Secreting Capacity of Specific CD8(+) T Cells Is Compromised While Increasing Copies of a Single T Cell Epitope Encoded by DNA Vaccine

por Wan, Yanmin, Wang, Jing, Zhou, Haizhu, Hu, Zhidong, Ren, Xiaonan, Xu, Jianqing
Publicado 2012

Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination

por Ren, Yanqin, Wang, Na, Hu, Weiguo, Zhang, Xiaoyan, Xu, Jianqing, Wan, Yanmin
Publicado 2015

From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD)

por He, Xiangchuan, Zhang, Miaomiao, Zhao, Chen, Zheng, Peiyong, Zhang, Xiaoyan, Xu, Jianqing
Publicado 2020

Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing

por Liao, Qibin, He, Huan, Mao, Yunyu, Ding, Xiangqing, Zhang, Xiaoyan, Xu, Jianqing
Publicado 2020

PD-L1 chimeric costimulatory receptor improves the efficacy of CAR-T cells for PD-L1-positive solid tumors and reduces toxicity in vivo

por Liao, Qibin, Mao, Yunyu, He, Huan, Ding, Xiangqing, Zhang, Xiaoyan, Xu, Jianqing
Publicado 2020

Recruitment of HIV-1 target cells at topical mucosal sites: a sensitive and early marker for determining the safety of microbicide candidates

por Li, Liangzhu, Ben, Yinyin, Yuan, Songhua, Liu, Aiping, Wu, Huanmei, Xu, Jianqing, Zhang, Xiaoyan
Publicado 2013

Exosomes for Immunoregulation and Therapeutic Intervention in Cancer

por Zhang, Xuan, Pei, Zenglin, Chen, Jinyun, Ji, Chunxia, Xu, Jianqing, Zhang, Xiaoyan, Wang, Jin
Publicado 2016

Identification of differentially expressed circular RNAs in human monocyte derived macrophages response to Mycobacterium tuberculosis infection

por Huang, Zikun, Su, Rigu, Deng, Zhen, Xu, Jianqing, Peng, Yiping, Luo, Qing, Li, Junming
Publicado 2017